← SynDRA
DAPHNETIN
SynDRA canonical compound SYN0007459 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Mechanism of action | protein kinase inhibitor |
|---|
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- PRKACA
- MCL1
- EGFR
- ALDH1A1
- PDPK1
- POLB
- PMP22
- PLK4
- PLK1
- PIN1
- PIM3
- PIM2
- PIM1
- PBK
- POLI
- PAK6
- PAK5
- PAK4
- OXSR1
- NPSR1
- NEK6
- NEK2
- MPHOSPH8
- MAPT
- POLH
- POLK
- MAPK3
- PRKAA2
- VRK2
- VRK1
- TNIK
- THRB
- THPO
- TDP1
- STK4
- STK38
- STK26
- STK25
- STK17A
- STK16
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ADCY9
- CP1A2
- CP3A7
- DPOLB
- HS90A
- HS90B
- LOX15
- NTM1A
- PRKACB
- PRKACG
Cross-references
Synonyms
- NSC-633563
- 7,8-Dihydroxycoumarin
- Daphnetol
- 7,8-Dihydroxy-2H-chromen-2-one
- 7,8-Dihydroxy-2H-1-benzopyran-2-one
- 7,8-dihydroxychromen-2-one
- 2H-1-Benzopyran-2-one, 7,8-dihydroxy-
- NSC 633563
- XC84571RD2
- CHEBI:17313
- RefChem:585182
- DTXCID60120051
- MFCD00016977
- 7,8-DIHYDROXY-2H-BENZOPYRAN-2-ONE
- COUMARIN, 7,8-DIHYDROXY-
- TCMDC-125839
- NSC633563
- SMR001230713
- SR-01000075820
- EINECS 207-632-8
- BRN 0009372
- daphnetine
- UNII-XC84571RD2
- 7,8-DIHYDROXY-CHROMEN-2-ONE
- Daphnetin (Standard)
- 1,8-Dihydroxycoumarin
- Daphnetin [WHO-DD]
- 7,8-dihydroxy-coumarin
- SpecPlus_000864
- 4,8-Dihydroxycoumarin;
- DAPHNETIN [MI]
- Spectrum3_000784
- Spectrum4_001254
- Lopac-D-5564
- A1L8C
- Lopac0_000330
- Oprea1_044324
- BSPBio_002488
Look up DAPHNETIN in the interactive SynDRA portal →